Literature DB >> 27500390

Optimal sequencing of postoperative radiotherapy and chemotherapy in IIIA-N2 non-small cell lung cancer.

Ugur Selek1, Joe Y Chang2.   

Abstract

Entities:  

Year:  2016        PMID： 27500390      PMCID： PMC4958859          DOI： 10.21037/jtd.2016.05.16

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  37 in total

Review 1.  ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung.

Authors:  Ramesh S Gopal; Sarita Dubey; Kenneth E Rosenzweig; Joe Yujiao Chang; Roy Decker; Richard M Gewanter; Feng-Ming Kong; Brian E Lally; Corey J Langer; Hoon Ku Lee; Benjamin Movsas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-31       Impact factor: 7.038

2.  Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with N2 mediastinal involvement.

Authors:  Cecile Le Péchoux; Ariane Dunant; Jean-Pierre Pignon; Dirk De Ruysscher; Françoise Mornex; Suresh Senan; Francesc Casas; Allan Price; Bernard Milleron
Journal:  J Clin Oncol       Date:  2007-03-01       Impact factor: 44.544

3.  A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques.

Authors:  B Dautzenberg; R Arriagada; A B Chammard; A Jarema; M Mezzetti; K Mattson; J L Lagrange; C Le Pechoux; B Lebeau; C Chastang
Journal:  Cancer       Date:  1999-07-15       Impact factor: 6.860

4.  Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.

Authors:  John L Mikell; Theresa W Gillespie; William A Hall; Dana C Nickleach; Yuan Liu; Joseph Lipscomb; Suresh S Ramalingam; Raj S Rajpara; Seth D Force; Felix G Fernandez; Taofeek K Owonikoko; Rathi N Pillai; Fadlo R Khuri; Walter J Curran; Kristin A Higgins
Journal:  J Thorac Oncol       Date:  2015-03       Impact factor: 15.609

5.  Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.

Authors:  Brian E Lally; Daniel Zelterman; Joseph M Colasanto; Bruce G Haffty; Frank C Detterbeck; Lynn D Wilson
Journal:  J Clin Oncol       Date:  2006-06-12       Impact factor: 44.544

6.  Is the time interval between surgery and radiotherapy important in operable nonsmall cell lung cancer? A retrospective analysis of 340 cases.

Authors:  F Würschmidt; H Bünemann; M Ehnert; H P Heilmann
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-10-01       Impact factor: 7.038

7.  Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial.

Authors:  Lucio Trodella; Pierluigi Granone; Salvatore Valente; Vincenzo Valentini; Mario Balducci; Giovanna Mantini; Adriana Turriziani; Stefano Margaritora; Alfredo Cesario; Sara Ramella; Giuseppe M Corbo; Rolando M D'Angelillo; Antonella Fontana; Domenico Galetta; Numa Cellini
Journal:  Radiother Oncol       Date:  2002-01       Impact factor: 6.280

8.  A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal disease.

Authors:  Bingwen Zou; Yong Xu; Tao Li; Wenhui Li; Bangxian Tang; Lin Zhou; Lu Li; Yongmei Liu; Jiang Zhu; Meijuan Huang; Jin Wang; Li Ren; Youlin Gong; Guowei Che; Lunxu Liu; Mei Hou; You Lu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-21       Impact factor: 7.038

9.  Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data.

Authors:  R Arriagada; A Auperin; S Burdett; J P Higgins; D H Johnson; T Le Chevalier; C Le Pechoux; M K B Parmar; J P Pignon; R L Souhami; R J Stephens; L A Stewart; J F Tierney; H Tribodet; J van Meerbeeck
Journal:  Lancet       Date:  2010-03-24       Impact factor: 79.321

10.  Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy.

Authors:  Zhouguang Hui; Honghai Dai; Jun Liang; Jima Lv; Zongmei Zhou; Qinfu Feng; Zefen Xiao; Dongfu Chen; Hongxing Zhang; Weibo Yin; Luhua Wang
Journal:  Thorac Cancer       Date:  2015-04-24       Impact factor: 3.500
View more
  1 in total

Review 1.  Adjuvant treatment in lung cancer.

Authors:  Begoña Taboada Valladares; Patricia Calvo Crespo; Urbano Anido Herranz; Antonio Gómez Caamaño
Journal:  J Clin Transl Res       Date:  2021-04-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.